Literature DB >> 12660254

Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos.

Raoul Orvieto1.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially life-threatening complication of ovulation induction. The syndrome almost always presents either after hCG administration in susceptible patients or during early pregnancy. Despite many years of clinical experience, the pathophysiology is poorly understood and there is no reliable test to predict patients who will subsequently develop severe OHSS. Nevertheless, excessive estradiol (E(2)) levels are commonly used as a predictor for the development of severe OHSS. The aim of this debate is to challenge this E(2) mythos by demonstrating the reported versatility in the chosen E(2) level in which patients develop OHSS; present pathophysiological evidence which paradoxically supports a preventive rather than a detrimental effect of E(2) against OHSS, followed by a possible explanation which may sort out the aforementioned chaos. Additional studies are required to elucidate the pathophysiology of OHSS which may ultimately lead to new strategies in the prediction, prevention and treatment of severe OHSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660254     DOI: 10.1093/humrep/deg166

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

2.  Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?

Authors:  Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2016-07-22       Impact factor: 3.412

Review 3.  New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

Authors:  A Delbaere; G Smits; O Olatunbosun; R Pierson; G Vassart; S Costagliola
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

4.  Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?

Authors:  Weijie Xing; Haiyan Lin; Yu Li; Dongzi Yang; Wenjun Wang; Qingxue Zhang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

5.  Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI.

Authors:  Barbara Lawrenz; Leyla Depret Bixio; Carol Coughlan; Claus Yding Andersen; Laura Melado; Bhanu Kalra; Gopal Savjani; Human M Fatemi; Ajay Kumar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

6.  Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

Authors:  Raoul Orvieto
Journal:  J Ovarian Res       Date:  2013-11-05       Impact factor: 4.234

7.  The effect of early coasting on blastocyst development and outcome following blastocyst transfer in IVF/ICSI programme.

Authors:  Chandra Kailasam; Heather Griffith; Paul Wilson; Uma Gordon
Journal:  JBRA Assist Reprod       Date:  2018-11-01

Review 8.  Human Chorionic Gonadotrophin: New Pleiotropic Functions for an "Old" Hormone During Pregnancy.

Authors:  Virginie Gridelet; Sophie Perrier d'Hauterive; Barbara Polese; Jean-Michel Foidart; Michelle Nisolle; Vincent Geenen
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.